Media center

Meitar Represented PrimeSence, 3D sensing technology developer company, in its acquisition by a multinational corporation.

Meitar represented Conduit in its spin-off of ClientConnect, Conduit’s toolbar division, and the subsequent purchase of ClientConnect by Perion Network Ltd., a NASDAQ company, in an all stock transaction. Conduit’s shareholders and option holders received 81% of Perion shares in the transaction, which closed in January 2014.

Meitar represented NYSE-listed Covidien, a US medical device manufacture, in its acquisition of Given Imaging, a medical technology company that develops and manufactures the swallowable imaging capsules for endoscopy, for approximately $1 billion.

Meitar successfully represented Israeli cellular operators Partner and Cellcom in opposing motions to certify class actions against them related to the battery life of cellular devices. The motions were withdrawn.

Meitar represented Sapiens (TASE and NASDAQ: SPNS), a leading global provider of software solutions for the insurance industry, in its $40 million public offering.

Meitar represented the baby food importer Heinz – Remedia and the former CEO of the company in criminal proceedings involving charges of involuntary manslaughter arising from allegations of tainted baby formula. After five years of litigation, the court acquitted the former CEO of all charges relating to the baby formula. The State has filed an appeal of the acquittal, which is still pending.

Our firm represented Barclays Capital Inc. and Citigroup Global Markets Inc. in the $1.4 billion global notes offering by Israel Electric Corporation.